Results 81 to 90 of about 10,696 (166)

Ebola hemorrhagic fever under scope, view of knowledge, attitude and practice from rural Sudan in 2015

Journal of Infection and Public Health, 2017
Summary: Ebola hemorrhagic fever (EHF) is an emerging threat to public health. The last epidemic in West Africa had a great effect on the affected communities.
Mohamed M.G. Mohamed, Hussam M. Shwaib, Monica M. Fahim, Elhamy A. Ahmed, Mawadda K. Omer, Islam A. Monier, Siham A. Balla   +6 more
doaj   +1 more source

DNA vaccines elicit durable protective immunity against individual or simultaneous infections with Lassa and Ebola viruses in guinea pigs

Human Vaccines & Immunotherapeutics, 2017
We previously developed optimized DNA vaccines against both Lassa fever and Ebola hemorrhagic fever viruses and demonstrated that they were protective individually in guinea pig and nonhuman primate models.
Kathleen A. Cashman, Eric R. Wilkinson, Suzanne E. Wollen, Joshua D. Shamblin, Justine M. Zelko, Jeremy J. Bearss, Xiankun Zeng, Kate E. Broderick, Connie S. Schmaljohn   +8 more
doaj   +1 more source

Ebola hemorrhagic fever [PDF]

, 2020
openaire   +3 more sources

Assessment of Risk to the U.S. Population from the Ebola Disease Outbreak Caused by Bundibugyo Virus, 2026. [PDF]

MMWR Morb Mortal Wkly Rep
Richard DM, Routledge I, Koeller S, Ghinai I, Hsu CH, Chatham-Stephens K, Bruce BB, Kahn R, Holmdahl I.   +8 more
europepmc   +1 more source

Bundibugyo virus-perspectives for the current outbreak. [PDF]

Npj Viruses
Hoenen T.
europepmc   +1 more source

Notes from the Field: Outbreak of Ebola Disease Caused by Bundibugyo Virus - Democratic Republic of the Congo and Uganda, May 2026. [PDF]

MMWR Morb Mortal Wkly Rep
Zomahoun DL, Boyd MA, Honein MA, Montgomery JM, Zielinski-Gutierrez E, Meites E, Christie A, Pillai SK, CDC 2026 Ebola Response.   +8 more
europepmc   +1 more source

Griffithsin-mediated inhibition of cellular entry of hemorrhagic fever viruses and insights into its mechanisms. [PDF]

J Virol
Saito T, Furuyama W, Muthusinghe DS, Munyeku-Bazitama Y, Hattori T, Okabe M, Yokoyama T, Tanaka Y, Sakai R, Sakurai Y, Sakaguchi M, Tsukagoshi R, Coronado Barrios NS, Tipih T, Rosenke K, Marzi A, Igarashi M, Urata S, Maruyama J, Nanbo A, Takada A.   +20 more
europepmc   +1 more source

Achievements and Challenges in Therapy and Vaccines Development of Viral Hemorrhagic Fevers: An Up-to-Date Review. [PDF]

Pharmaceutics
Lupascu D, Iacob AT, Apotrosoaei M, Vasincu IM, Lupascu FG, Chirliu OM, Profire BS, Tauser RG, Profire L.   +8 more
europepmc   +1 more source

Healthcare-associated transmission and early IPC system vulnerabilities during the 2026 Bundibugyo Ebola outbreak in eastern Democratic Republic of the Congo. [PDF]

Antimicrob Resist Infect Control
Bepouka B, Kafua M.
europepmc   +1 more source

Modeled Scenario Projections for the Ebola Disease Outbreak Caused by Bundibugyo Virus, 2026. [PDF]

MMWR Morb Mortal Wkly Rep
Mooring EQ, Koval WT, Routledge I, Holmdahl I, Hudson K, España G, Kahn R, Bruce BB.   +7 more
europepmc   +1 more source